Epidemiology of a fast emerging disease in the Asia-Pacific region: Non-alcoholic fatty liver disease

Hepatology International

Volumn 7, Issue 1, 2013, Pages 65-71

  Wah Kheong, Chan ^a   Khean Lee, Goh ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Asia Pacific; Epidemiology; NAFLD

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASIA; ASIA PACIFIC REGION; CARDIOVASCULAR DISEASE; CHOLELITHIASIS; CHRONIC KIDNEY DISEASE; COLORECTAL POLYP; DIABETES MELLITUS; DISEASE SEVERITY; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GOUT; GROUPS BY AGE; HEPATITIS B; HEPATITIS C; HUMAN; HYPERURICEMIA; IMPAIRED GLUCOSE TOLERANCE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 84875240186     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-012-9384-1     Document Type: Review

References (66)

1. XH Hou YX Zhu HJ Lu, et al. 2011 Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese J Gastroenterol Hepatol 26 722 730 21418302 10.1111/j.1440-1746.2010.06509.x 1:CAS:528:DC%2BC3MXls1Kiur8%3D
2. AB Gao Q Xiao LY Li, et al. 2008 Epidemiological survey of the association between non alcoholic fatty liver disease and metabolic syndrome in civil servants of Chongqing city Zhonghua Yu Fang Yi Xue Za Zhi 42 107 110 18642663 1:CAS:528:DC%2BD1MXjtFWqtr4%3D
3. YJ Zhou YY Li YQ Nie, et al. 2007 Prevalence of fatty liver disease and its risk factors in the population of South China World J Gastroenterol 13 6419 6424 18081233 10.3748/wjg.13.6419
4. ZW Chen LY Chen HL Dai, et al. 2008 Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease J Zhejiang Univ Sci B 9 616 622 18763311 10.1631/jzus.B0720016 1:CAS:528:DC%2BD1cXhtVGht73O
5. Y Li C Xu C Yu, et al. 2009 Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study J Hepatol 50 1029 1034 19299029 10.1016/j.jhep.2008.11.021 1:CAS:528:DC%2BD1MXkslKksL8%3D
6. H Li YJ Wang K Tan, et al. 2009 Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China Hepatobiliary Pancreat Dis Int 8 377 382 19666406
7. WM Kang JS Zhang MS Wang, et al. 2009 Prevalence of metabolic syndrome and its associations with other metabolic disorders and cardiovascular changes in health examination population in Beijing Chin Med Sci J 24 227 230 20120769 10.1016/S1001-9294(10)60006-5
8. H Dai L Chu S Song, et al. 2009 Prevalence of and risk factors for fatty liver disease in a professional population of Wuhan, China Public Health 123 545 548 19674763 10.1016/j.puhe.2009.07.002 1:STN:280:DC%2BD1MnhsVGqtg%3D%3D
9. JG Fan J Zhu XJ Li, et al. 2005 Fatty liver and the metabolic syndrome among Shanghai adults J Gastroenterol Hepatol 20 1825 1832 16336439 10.1111/j.1440-1746.2005.04058.x
10. JG Fan F Li XB Cai, et al. 2007 The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers J Gastroenterol Hepatol 22 663 668 17444853 10.1111/j.1440-1746.2007.04892.x
11. Z Wang B Xia C Ma, et al. 2007 Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China Postgrad Med J 83 192 195 17344575 10.1136/pgmj.2006.052258
12. J Oya T Nakagami S Sasaki, et al. 2010 Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women Eur J Clin Nutr 64 1179 1185 20683463 10.1038/ejcn.2010.139 1:CAS:528:DC%2BC3cXht1Cgt7%2FO
13. S Jimba T Nakagami M Takahashi, et al. 2005 Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults Diabet Med 22 1141 1145 16108839 10.1111/j.1464-5491.2005.01582. x 1:CAS:528:DC%2BD2MXhtVOlt7%2FO
14. Y Saito K Yagyu Y Hattori, et al. 1989 A study on fatty liver in health examination participants Nihon Eiseigaku Zasshi 44 953 961 2642191 10.1265/jjh.44.953 1:STN:280:DyaK3czosVSmsQ%3D%3D
15. S Kojima N Watanabe M Numata, et al. 2003 Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background J Gastroenterol 38 954 961 14614602 10.1007/s00535-003-1178-8
16. M Akahoshi Y Amasaki M Soda, et al. 2001 Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan Hypertens Res 24 337 343 11510744 10.1291/hypres.24.337 1:STN:280:DC%2BD3Mvms1aitQ%3D%3D
17. SH Park WK Jeon SH Kim, et al. 2006 Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults J Gastroenterol Hepatol 21 138 143 16706825 10.1111/j.1440-1746.2005.04086.x
18. JC Bae YK Cho WY Lee, et al. 2010 Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects Am J Gastroenterol 105 2389 2395 20628364 10.1038/ajg.2010.275 1:CAS:528:DC%2BC3cXhtlOhsb7L
19. HJ Kim KE Lee DJ Kim, et al. 2004 Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults Arch Intern Med 164 2169 2175 15505132 10.1001/archinte.164.19.2169
20. CF Kuo KH Yu SF Luo, et al. 2010 Gout and risk of non-alcoholic fatty liver disease Scand J Rheumatol 39 466 471 20560813 10.3109/03009741003742797 1:CAS:528:DC%2BC3cXhsVyrurzO
21. CH Chen MH Huang JC Yang, et al. 2006 Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults J Clin Gastroenterol 40 745 752 16940890 10.1097/00004836-200609000-00016 1:CAS:528:DC%2BD28XovVWjtbw%3D
22. CH Tsai TC Li CC Lin 2008 Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease South Med J 101 900 905 18708987 10.1097/SMJ.0b013e31817e8af9
23. PJ Hsiao KK Kuo SJ Shin, et al. 2007 Significant correlations between severe fatty liver and risk factors for metabolic syndrome J Gastroenterol Hepatol 22 2118 2123 18031368 10.1111/j.1440-1746.2006.04698.x 1:CAS:528:DC%2BD1cXhtVKhsLo%3D
24. YC Lin HM Lo JD Chen 2005 Sonographic fatty liver, overweight and ischemic heart disease World J Gastroenterol 11 4838 4842 16097054
25. SW Lai CK Tan KC Ng 2002 Epidemiology of fatty liver in a hospital-based study in Taiwan South Med J 95 1288 1292 12539995
26. SN Lu LY Wang WY Chang, et al. 1990 Abdominal sonographic screening in a single community Gaoxiong Yi Xue Ke Xue Za Zhi 6 643 646 2266568 1:STN:280:DyaK3M%2FpsVSqsg%3D%3D
27. D Amarapurkar P Kamani N Patel, et al. 2007 Prevalence of non-alcoholic fatty liver disease: population based study Ann Hepatol 6 161 163 17786142
28. V Mohan S Farooq M Deepa, et al. 2009 Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome Diabetes Res Clin Pract 84 84 91 19168251 10.1016/j.diabres.2008.11.039 1:CAS:528:DC%2BD1MXjsV2ltb8%3D
29. SP Singh S Nayak M Swain, et al. 2004 Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey Trop Gastroenterol 25 76 79 15471321
30. K Das PS Mukherjee A Ghosh, et al. 2010 Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease Hepatology 51 1593 1602 20222092 10.1002/hep.23567 1:CAS:528:DC%2BC3cXntFCqtbo%3D
31. AS Dassanayake A Kasturiratne S Rajindrajith, et al. 2009 Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population J Gastroenterol Hepatol 24 1284 1288 19476560 10.1111/j.1440-1746.2009.05831.x
32. S Zelber-Sagi D Nitzan-Kaluski Z Halpern, et al. 2006 Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures Liver Int 26 856 863 16911469 10.1111/j.1478-3231.2006.01311.x
33. K Rungsinaporn T Phaisakamas 2008 Frequency of abnormalities detected by upper abdominal ultrasound J Med Assoc Thai 91 1072 1075 18839847
34. Goh SC, Ho E, Goh KL (2012) Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia. Hepatology International 2012, published online
35. L Caballeria G Pera MA Auladell, et al. 2010 Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain Eur J Gastroenterol Hepatol 22 24 32 19730384 10.1097/MEG.0b013e32832fcdf0 1:CAS:528:DC%2BD1MXhsFSrur3F
36. G Bedogni L Miglioli F Masutti, et al. 2005 Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study Hepatology 42 44 52 15895401 10.1002/hep.20734
37. YP Wan RY Xu H Fang, et al. 2007 The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai Zhonghua Gan Zang Bing Za Zhi 15 644 648 17903363
38. G Tsuruta N Tanaka M Hongo, et al. 2010 Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits J Gastroenterol 45 666 672 20084525 10.1007/s00535-009-0198-4
39. K Tominaga JH Kurata YK Chen, et al. 1995 Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey Dig Dis Sci 40 2002 2009 7555456 10.1007/BF02208670 1:STN:280:DyaK28%2FivFamsw%3D%3D
40. SM Alavian AH Mohammad-Alizadeh F Esna-Ashari, et al. 2009 Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures Liver Int 29 159 163 18492015 10.1111/j.1478-3231.2008.01790.x 1:CAS:528: DC%2BD1MXisV2rt7Y%3D
41. A Adibi R Kelishadi A Beihaghi, et al. 2009 Sonographic fatty liver in overweight and obese children, a cross sectional study in Isfahan Endokrynol Pol 60 14 19 19224500
42. HB Shi JF Fu L Liang, et al. 2009 Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children Zhonghua Er Ke Za Zhi 47 114 118 19573457
43. JF Fu L Liang CL Wang, et al. 2006 Nonalcoholic steatohepatitis in obese children: the prevalence and possible mechanism Zhejiang Da Xue Xue Bao Yi Xue Ban 35 64 68 16470923 1:CAS:528:DC%2BD2sXnvFSqtbY%3D
44. R Sagi S Reif G Neuman, et al. 2007 Nonalcoholic fatty liver disease in overweight children and adolescents Acta Paediatr 96 1209 1213 17655622 10.1111/j.1651-2227.2007.00399.x 1:STN:280:DC%2BD2svjvVSmtw%3D%3D
45. JG Fang J Zhu XJ Li, et al. 2005 Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai Zhonghua Gan Zang Bing Za Zhi 13 83 88 15727689
46. OT Ayonrinde JK Olynyk LJ Beilin, et al. 2011 Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease Hepatology 53 800 809 21374659 10.1002/hep.24097 1:CAS:528:DC%2BC3MXkt1Cltr0%3D
47. CH Chen MH Huang JC Yang, et al. 2007 Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan J Gastroenterol Hepatol 22 1482 1489 17716352 10.1111/j.1440-1746.2006.04615.x 1:CAS:528:DC%2BD2sXhtFGgtLfJ
48. R Jamali M Khonsari S Merat, et al. 2008 Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes World J Gastroenterol 14 2867 2871 18473412 10.3748/wjg.14.2867 1:CAS:528:DC%2BD1cXpsFOksbc%3D
49. T Yamada M Fukatsu S Suzuki, et al. 2010 Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup J Gastroenterol Hepatol 25 352 356 19817963 10.1111/j.1440-1746.2009. 05998.x 1:CAS:528:DC%2BC3cXjtlGmsLg%3D
50. M Shibata Y Kihara M Taguchi, et al. 2007 Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men Diabetes Care 30 2940 2944 17666460 10.2337/dc07-0792 1:CAS:528: DC%2BD2sXhtlKhs7vF
51. AK Agarwal V Jain S Singla, et al. 2011 Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes J Assoc Physicians India 59 351 354 21751587 1:STN:280:DC%2BC3MnnvVKmug%3D%3D
52. J Zhou WP Jia YQ Bao, et al. 2007 Study on prevalence and risk factors of fatty liver of patients with type 2 diabetes Zhonghua Yi Xue Za Zhi 87 2249 2252 18001543 1:CAS:528:DC%2BD1cXhtFCmt7zJ
53. VW Wong AY Hui SW Tsang, et al. 2006 Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease Aliment Pharmacol Ther 24 1215 1222 17014580 10.1111/j.1365-2036. 2006.03112.x 1:STN:280:DC%2BD28rosVajtA%3D%3D
54. N Assy A Djibre R Farah, et al. 2010 Presence of coronary plaques in patients with nonalcoholic fatty liver disease Radiology 254 393 400 20093511 10.1148/radiol.09090769
55. H Fotbolcu T Yakar D Duman, et al. 2010 Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease Cardiol J 17 457 463 20865675
56. C Aygun O Kocaman T Sahin, et al. 2008 Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease Dig Dis Sci 53 1352 1357 17939039 10.1007/s10620-007-9998-7
57. K Yasui Y Sumida Y Mori, et al. 2011 Nonalcoholic steatohepatitis and increased risk of chronic kidney disease Metabolism 60 735 739 20817213 10.1016/j.metabol.2010.07.022 1:CAS:528:DC%2BC3MXkvVCkur8%3D
58. CH Chen MH Huang JC Yang, et al. 2006 Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey J Gastroenterol Hepatol 21 1737 1743 16984599 10.1111/j.1440-1746.2006.04381.x
59. ST Hwang YK Cho JH Park, et al. 2010 Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps J Gastroenterol Hepatol 25 562 567 20074156 10.1111/j.1440-1746.2009.06117.x 1:CAS:528:DC%2BC3cXlt1Siu7s%3D
60. MM Brzozowska G Ostapowicz MD Weltman 2009 An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome J Gastroenterol Hepatol 24 243 247 19215335 10.1111/j.1440-1746.2008.05740.x 1:CAS:528:DC%2BD1MXjslKksrw%3D
61. JP Shi JG Fan R Wu, et al. 2008 Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection J Gastroenterol Hepatol 23 1419 1425 18853998 10.1111/j.1440-1746.2008.05531.x
62. JW Yun YK Cho JH Park, et al. 2009 Hepatic steatosis and fibrosis in young men with treatment-naive chronic hepatitis B Liver Int 29 878 883 19192167 10.1111/j.1478-3231.2009.01976.x 1:CAS:528:DC%2BD1MXovFShsLs%3D
63. SJ Hwang JC Luo CW Chu, et al. 2001 Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation J Gastroenterol Hepatol 16 190 195 11207900 10.1046/j.1440-1746.2001.02407.x 1:STN:280:DC%2BD3MvjsVKgtA%3D%3D
64. CJ Liu YM Jeng PJ Chen, et al. 2005 Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C Antivir Ther 10 405 415 15918331 1:CAS:528: DC%2BD2MXmtFGqsrs%3D
65. AM Ahmed MS Hassan A Abd-Elsayed, et al. 2011 Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection Saudi J Gastroenterol 17 245 251 21727730 10.4103/1319-3767.82578
66. M Minakari FK Sameni HM Shalmani, et al. 2008 Hepatic steatosis in Iranian patients with chronic hepatitis C Med Princ Pract 17 126 130 18287796 10.1159/000112966